Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.
暂无分享,去创建一个
H. Brenner | M. Pawlita | Lei Gao | A. Michel | M. Weck
[1] M. Vieth,et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study , 2008, Scandinavian journal of gastroenterology.
[2] H. Brenner,et al. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff‐value , 2007, International journal of cancer.
[3] P. Correa,et al. Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.
[4] A. Svennerholm,et al. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. , 2007, Vaccine.
[5] F. Clavel-Chapelon,et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC‐EURGAST study , 2007, International journal of cancer.
[6] M. Chung,et al. Quantitative Analysis of Representative Proteome Components and Clustering of Helicobacter pylori Clinical Strains , 2006, Helicobacter.
[7] Y. Goto,et al. Genetic factors involved in the development of Helicobacter pylori‐related gastric cancer , 2006, Cancer science.
[8] D. Kang,et al. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case–control study in Korea , 2006, British Journal of Cancer.
[9] Ding-Shinn Chen,et al. Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer * S , 2006, Molecular & Cellular Proteomics.
[10] H. Brenner,et al. Prevalence of Chronic Atrophic Gastritis in Different Parts of the World , 2006, Cancer Epidemiology Biomarkers & Prevention.
[11] A. Scaloni,et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] G. Bergonzelli,et al. GroEL of Lactobacillus johnsonii La1 (NCC 533) Is Cell Surface Associated: Potential Role in Interactions with the Host and the Gastric Pathogen Helicobacter pylori , 2006, Infection and Immunity.
[13] D. Forman,et al. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. , 2006, Best practice & research. Clinical gastroenterology.
[14] D. Graham,et al. Helicobacter pylori virulence factors: facts and fantasies , 2005, Current opinion in gastroenterology.
[15] Markus F Templin,et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.
[16] P. Mittl,et al. Characterization of the Helicobacter pylori Cysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent , 2005, Infection and Immunity.
[17] V. Govorun,et al. Comparative Analysis of Transcription Profiles of Helicobacter pylori Clinical Isolates , 2005, Biochemistry (Moscow).
[18] T. Meyer,et al. Identification of candidate antigens for serologic detection of Helicobacter pylori‐infected patients with gastric carcinoma , 2004, International journal of cancer.
[19] S. Dhar,et al. Molecular mechanism of action of major Helicobacter pylori virulence factors , 2003, Molecular and Cellular Biochemistry.
[20] I. Zuna,et al. Serum Antibodies Against Helicobacter pylori Proteins VacA and CagA Are Associated with Increased Risk for Gastric Adenocarcinoma , 1997, Digestive Diseases and Sciences.
[21] R. Hunt,et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.
[22] P. Mittl,et al. Detection of High Titers of Antibody against Helicobacter Cysteine-Rich Proteins A, B, C, and E in Helicobacter pylori-Infected Individuals , 2003, Clinical Diagnostic Laboratory Immunology.
[23] J. Virtamo,et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[24] R. Haas,et al. Identification and Characterization of Helicobacter pylori Genes Essential for Gastric Colonization , 2003, The Journal of experimental medicine.
[25] S. Hazell,et al. Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. , 2003, Microbiology.
[26] Nayoung Kim,et al. Proteins Released by Helicobacter pylori In Vitro , 2002, Journal of bacteriology.
[27] T. Meyer,et al. Multiparameter Selection of Helicobacter pylori Antigens Identifies Two Novel Antigens with High Protective Efficacy , 2002, Infection and Immunity.
[28] Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study , 2002, Gut.
[29] Toni Aebischer,et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease , 2002, Proteomics.
[30] J. d'Alayer,et al. Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients , 2002, Journal of Clinical Microbiology.
[31] M. Blaser,et al. Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.
[32] R. Haas,et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2003, Molecular microbiology.
[33] R. Haas,et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2001 .
[34] Y. Shiratori,et al. Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil , 2000, The Journal of experimental medicine.
[35] R. Rappuoli,et al. The Neutrophil-Activating Protein (Hp-Nap) of Helicobacter pylori Is a Protective Antigen and a Major Virulence Factor , 2000, The Journal of experimental medicine.
[36] W. Goebel,et al. Identification of Immunodominant Antigens fromHelicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies , 2000, Infection and Immunity.
[37] A. Munakata,et al. VacA seropositivity is not associated with the development of gastric cancer in a Japanese population. , 1999, European journal of gastroenterology & hepatology.
[38] R. Rappuoli,et al. Helicobacter pylori virulence and genetic geography. , 1999, Science.
[39] E. J. Kuipers,et al. Review article: exploring the link between Helicobacter pylori and gastric cancer , 1999, Alimentary pharmacology & therapeutics.
[40] G. Perez-Perez,et al. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico , 1998, International journal of cancer.
[41] T. Monath,et al. Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against Helicobacter pyloriInfection , 1998, Infection and Immunity.
[42] T. Fujioka,et al. Biopsy Sites Suitable for the Diagnosis of Helicobacter pylori Infection and the Assessment of the Extent of Atrophic Gastritis , 1998, American Journal of Gastroenterology.
[43] I. Corthésy-Theulaz,et al. Mice Are Protected from Helicobacter pylori Infection by Nasal Immunization with AttenuatedSalmonella typhimurium phoPc Expressing Urease A and B Subunits , 1998, Infection and Immunity.
[44] M. Blaser,et al. Pathogenesis of the transformation from gastritis to malignancy , 1998, Alimentary pharmacology & therapeutics.
[45] H. Mobley,et al. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. , 1996, The American journal of medicine.
[46] I. Kansau,et al. Heat shock proteins of Helicobacter pylori. , 1996, Alimentary pharmacology & therapeutics.
[47] K. Chapman. An international perspective on anticholinergic therapy. , 1996, The American journal of medicine.
[48] E. Kuipers,et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.
[49] M. Dixon,et al. Observer variation in the assessment of chronic gastritis according to the Sydney system , 1994, Histopathology.
[50] W. Karnes,et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.
[51] M. Blaser. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. , 1990, The Journal of infectious diseases.
[52] S. Tannenbaum,et al. A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1975, The Lancet.